UMIN000051712
Comparison between stereotactic body radiotherapy and transcatheter arterial chemoembolization for hepatocellular carcinoma: Meta-analysis and systematic review.
Yokohama City University Medical Center·University Hospital Medical Information NetworkRecruitment Completed
Study focus
- Disease/Condition
- Hepatocellular carcinoma
Sponsor & location
- Primary sponsor
- Yokohama City University Medical Center
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Jul 26, 2023
- End date
- N/A
ICD-10 classifications
Malignant neoplasm: HepatoblastomaMalignant neoplasm: Liver cell carcinomaMalignant neoplasm: Other specified carcinomas of liverMalignant neoplasm: Liver, unspecifiedMalignant neoplasm: Hepatic flexure
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000051712
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000051712 through Pure Global AI's free database. This phase not specified trial is sponsored by Yokohama City University Medical Center and is currently Recruitment Completed. The study focuses on Hepatocellular carcinoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.